(Q38986871)

8 September 2017

The Neuroprotective Effect of Erythropoietin on Rotenone-Induced Neurotoxicity in SH-SY5Y Cells Through the Induction of Autophagy (English)

1 reference

8 September 2017

0 references

1 reference

1 reference

1 reference

Wooyoung Jang

1

1 reference

8 September 2017

Hee Ju Kim

2

1 reference

8 September 2017

Huan Li

3

1 reference

8 September 2017

Kwang Deog Jo

4

1 reference

8 September 2017

Moon Kyu Lee

5

1 reference

8 September 2017

Hyun Ok Yang

6

1 reference

8 September 2017

9 July 2015

1 reference

8 September 2017

Molecular Neurobiology

1 reference

8 September 2017

53

1 reference

8 September 2017

6

1 reference

8 September 2017

3812-3821

1 reference

https://scigraph.springernature.com/pub.10.1007/s12035-015-9316-x

8 September 2017

0 references

cites work

Parkinson disease: from pathology to molecular disease mechanisms.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Clinical practice. Diagnosis and initial management of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Molecular pathogenesis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

α-Synuclein and protein degradation systems: a reciprocal relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

The role of autophagy in Parkinson's disease: rotenone-based modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Autophagy: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Rapamycin protects against rotenone-induced apoptosis through autophagy induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

The Parkinson disease protein α-synuclein inhibits autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

1,25-Dyhydroxyvitamin D₃ attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Emerging biological roles for erythropoietin in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Erythropoietin enhances hippocampal long-term potentiation and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Erythropoietin modulates autophagy signaling in the developing rat brain in an in vivo model of oxygen-toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

LAMP2A as a therapeutic target in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

AMPK -> ULK1 -> autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

L-DOPA neurotoxicity is prevented by neuroprotective effects of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Investigating the role of reactive oxygen species in regulating autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Autophagy and disease: always two sides to a problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Autophagy in Huntington disease and huntingtin in autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9316-X

alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.

21 January 2018

1 reference

12 December 2020

Use of Cuban recombinant human erythropoietin in Parkinson's disease treatment.

1 reference

12 December 2020

Erythropoietin: structure, control of production, and function

1 reference

12 December 2020

Non-erythroid functions of erythropoietin

1 reference

12 December 2020

The role of autophagy in Parkinson's disease.

1 reference

12 December 2020

10.1007/S12035-015-9316-X

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

0 references

1 reference